Cullinan Associates’s GSK GSK Stock Holding History

Cullinan Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,320	Closed	-$282K	–	226
2021 Q1	$282K	Buy	6,320 +160	+3%	+$7.14K	0.02%	189
2020 Q4	$283K	Buy	6,160 +80	+1%	+$3.68K	0.02%	173
2020 Q3	$286K	Buy	6,080 +240	+4%	+$11.3K	0.02%	161
2020 Q2	$298K	Sell	5,840 -640	-10%	-$32.7K	0.02%	160
2020 Q1	$307K	Sell	6,480 -15,200	-70%	-$720K	0.03%	149
2019 Q4	$1.27M	Sell	21,680 -720	-3%	-$42.3K	0.09%	120
2019 Q3	$1.2M	Buy	22,400 +640	+3%	+$34.1K	0.09%	122
2019 Q2	$1.09M	Sell	21,760 -1,600	-7%	-$80.1K	0.08%	128
2019 Q1	$1.22M	Sell	23,360 -240	-1%	-$12.5K	0.09%	126
2018 Q4	$1.13M	Buy	23,600 +5,040	+27%	+$241K	0.09%	120
2018 Q3	$932K	Sell	18,560 -720	-4%	-$36.2K	0.07%	132
2018 Q2	$971K	Sell	19,280 -1,680	-8%	-$84.6K	0.07%	129
2018 Q1	$1.02M	Sell	20,960 -80	-0.4%	-$3.91K	0.08%	127
2017 Q4	$933K	Buy	21,040 +8,960	+74%	+$397K	0.07%	134
2017 Q3	$613K	Buy	12,080 +1,359	+13%	+$69K	0.05%	152
2017 Q2	$578K	Buy	10,721 +800	+8%	+$43.1K	0.05%	158
2017 Q1	$523K	Sell	9,921 -3,872	-28%	-$204K	0.04%	165
2016 Q4	$664K	Buy	13,793 +376	+3%	+$18.1K	0.06%	155
2016 Q3	$723K	Buy	13,417 +1,200	+10%	+$64.7K	0.06%	149
2016 Q2	$662K	Buy	12,217 +3,760	+44%	+$204K	0.05%	148
2016 Q1	$429K	Buy	8,457 +480	+6%	+$24.3K	0.04%	162
2015 Q4	$402K	Sell	7,977 -800	-9%	-$40.3K	0.04%	167
2015 Q3	$422K	Buy	8,777 +560	+7%	+$26.9K	0.04%	180
2015 Q2	$428K	Sell	8,217 -160	-2%	-$8.33K	0.04%	179
2015 Q1	$483K	Buy	+8,377	New	+$483K	0.04%	178
2014 Q4	–	Sell	-27,097	Closed	-$1.56M	–	90
2014 Q3	$1.56M	Buy	+27,097	New	+$1.56M	0.18%	69
2014 Q2	–	Sell	-30,537	Closed	-$2.04M	–	88
2014 Q1	$2.04M	Buy	30,537 +11,600	+61%	+$775K	0.23%	56
2013 Q4	$1.26M	Buy	18,937 +7,280	+62%	+$486K	0.15%	65
2013 Q3	$731K	Buy	+11,657	New	+$731K	0.1%	78